TMCnet News

Immunodiagnostics Market in China to Grow at a CAGR of Close to 19% in 2020, According to Technavio
[March 21, 2016]

Immunodiagnostics Market in China to Grow at a CAGR of Close to 19% in 2020, According to Technavio


According to the latest market study released by Technavio, the immunodiagnostics market in China is set to reach USD 2.9 billion by 2020, growing at remarkable CAGR of close to 19%.

This research report titled 'Immunodiagnostics Market in China 2016-2020,' provides an in-depth analysis of the market in terms of revenue and emerging market trends. This market research report also includes up to date analysis and forecasts for various market segments and all geographical regions.

Request sample report: http://goo.gl/joSIVM

The immunodiagnostics market in China is segmented into three different mode of operation:

  • Automated systems
  • Semi-automated systems
  • Manual systems

Semi-automated systems

Semi-automated systems are open systems where limited manual intervention is involved to process and analyze samples. They are used for plate washing, sample or reagent addition, and incubation. A majority of these systems are standalone immunoanalysis systems that are available as large-, medium-, and small-sized instruments, which cater to different clinical and laboratory applications.

"Semi-automated systems have a share of more than 55% in the immunodiagnostics market in China. They are preferred by small- and medium-sized facilities," says Barath Palada, a lead analyst at Technavio for in-vitro diagnostics.

However, the report indicates that increasing preference for automated systems will have an impact on the adoption of semi-automated systems in the future. The majority of local vendors in China offer these systems at affordable prices.

Automated systems

Automated systems account for a 37.15% share of the market in 2015, with both foreign and local vendors offering them. Automated analyzers are usually employed in laboratories for HTS. They also help limit the manual and sample processing errors to render he most accurate results. The sample processing and analysis is highly streamlined, with no manual intervention during the aliquot preparation. These analyzers are employed in large-, medium-, and small- sized clinical laboratories.



"In China, automated systems are employed in almost all Class III hospitals and in a limited number of Class II hospitals, indicating that the market for automated analyzers is growing in the region," says Barath.

Manual systems


Manual screening methods are adopted in primary healthcare centers, especially in towns and villages, due to limited budgets. The manually used instruments segment holds 7.50% of the market. Government initiatives to increase healthcare budgets and upgrade hospitals to the standard norms of hospital classification is expected to boost the adoption of automated systems in these institutions, plummeting the growth and share of manual instruments in the market during the forecast period.

Competitive vendor landscape

The competition in the immunodiagnostics market in China is intense because of the growing demand for immunodiagnostics tests and their impact on medical decisions. The growing older population and urbanization have put forth huge opportunities for vendors to grow and expand their businesses. Further, the rise in the number of hospitals and increase in adoption of immunodiagnostic tests at grassroots levels have presented new opportunities for vendors. The introduction and effective implementation of healthcare reforms benefits large manufacturers as almost every citizen in the country undergoing diagnosis and treatment will be covered under reimbursements.

Key news:

  • July 2015: DIAsource 25OH Vitamin D ELISA is cleared by the CFDA
  • July 2015: DiaSorin and Beckman Coulter sign a distribution partnership agreement to market their products for hepatitis and human immunodeficiency virus (HIV) test in China.
  • July 2015: Roche Diagnostics introduces two new tests to its serology assay portfolio, which will help detect the human T-lymphotropic virus-I/II infection in donated blood samples

The top vendors highlighted by Technavio's research analysts in this report are:

  • Abbott Diagnostics
  • Beckman Coulter Trading (China)
  • bioMérieux China
  • DiaSorin
  • Mindray
  • Roche Diagnostics
  • Siemens (News - Alert) Healthcare Diagnostics (Shanghai)
  • Sysmex Medical Electronics (Shanghai)

Browse Related Reports:

Purchase these three reports for the price of one by becoming a Technavio subscriber. Subscribing to Technavio's reports allows you to download any three reports per month for the price of one. Contact [email protected] with your requirements and a link to our subscription platform.

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.

If you are interested in more information, please contact our media team at [email protected].


[ Back To TMCnet.com's Homepage ]